Obesity Treatment-North America Market Status and Trend Report 2013-2023
Report Summary
Obesity Treatment-North America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Obesity Treatment industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole North America and Regional Market Size of Obesity Treatment 2013-2017, and development forecast 2018-2023
Main market players of Obesity Treatment in North America, with company and product introduction, position in the Obesity Treatment market
Market status and development trend of Obesity Treatment by types and applications
Cost and profit status of Obesity Treatment, and marketing status
Market growth drivers and challenges
The report segments the North America Obesity Treatment market as:
North America Obesity Treatment Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
United States
Canada
Mexico
North America Obesity Treatment Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Surgical & Implant Devices
Medication Therapy
Dietary
Other
North America Obesity Treatment Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Children
Adults
North America Obesity Treatment Market: Players Segment Analysis (Company and Product introduction, Obesity Treatment Sales Volume, Revenue, Price and Gross Margin):
NutriSystem, Inc. (U.S.)
Kellogg Company (U.S.)
Ethicon, Inc. (U.S.)
Medtronic (U.S.)
F. Hoffmann-La Roche (Switzerland)
Atkins Nutritionals, Inc. (U.S.)
Herbalife Ltd. (U.S.)
Covidien plc (U.S.)
Apollo Endosurgery (U.S.)
Amer Sports (Finland)
Johnson Health Technology, Ltd. (Taiwan)
Cybex International (U.S.)
USGI Medical (U.S.)
Olympus Corporation (Japan)
Brunswick Corporation (U.S.)
Technogym SpA (Italy)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Obesity Treatment-North America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Obesity Treatment industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole North America and Regional Market Size of Obesity Treatment 2013-2017, and development forecast 2018-2023
Main market players of Obesity Treatment in North America, with company and product introduction, position in the Obesity Treatment market
Market status and development trend of Obesity Treatment by types and applications
Cost and profit status of Obesity Treatment, and marketing status
Market growth drivers and challenges
The report segments the North America Obesity Treatment market as:
North America Obesity Treatment Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
United States
Canada
Mexico
North America Obesity Treatment Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Surgical & Implant Devices
Medication Therapy
Dietary
Other
North America Obesity Treatment Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Children
Adults
North America Obesity Treatment Market: Players Segment Analysis (Company and Product introduction, Obesity Treatment Sales Volume, Revenue, Price and Gross Margin):
NutriSystem, Inc. (U.S.)
Kellogg Company (U.S.)
Ethicon, Inc. (U.S.)
Medtronic (U.S.)
F. Hoffmann-La Roche (Switzerland)
Atkins Nutritionals, Inc. (U.S.)
Herbalife Ltd. (U.S.)
Covidien plc (U.S.)
Apollo Endosurgery (U.S.)
Amer Sports (Finland)
Johnson Health Technology, Ltd. (Taiwan)
Cybex International (U.S.)
USGI Medical (U.S.)
Olympus Corporation (Japan)
Brunswick Corporation (U.S.)
Technogym SpA (Italy)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF OBESITY TREATMENT
1.1 Definition of Obesity Treatment in This Report
1.2 Commercial Types of Obesity Treatment
1.2.1 Surgical & Implant Devices
1.2.2 Medication Therapy
1.2.3 Dietary
1.2.4 Other
1.3 Downstream Application of Obesity Treatment
1.3.1 Children
1.3.2 Adults
1.4 Development History of Obesity Treatment
1.5 Market Status and Trend of Obesity Treatment 2013-2023
1.5.1 North America Obesity Treatment Market Status and Trend 2013-2023
1.5.2 Regional Obesity Treatment Market Status and Trend 2013-2023
CHAPTER 2 NORTH AMERICA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Obesity Treatment in North America 2013-2017
2.2 Consumption Market of Obesity Treatment in North America by Regions
2.2.1 Consumption Volume of Obesity Treatment in North America by Regions
2.2.2 Revenue of Obesity Treatment in North America by Regions
2.3 Market Analysis of Obesity Treatment in North America by Regions
2.3.1 Market Analysis of Obesity Treatment in United States 2013-2017
2.3.2 Market Analysis of Obesity Treatment in Canada 2013-2017
2.3.3 Market Analysis of Obesity Treatment in Mexico 2013-2017
2.4 Market Development Forecast of Obesity Treatment in North America 2018-2023
2.4.1 Market Development Forecast of Obesity Treatment in North America 2018-2023
2.4.2 Market Development Forecast of Obesity Treatment by Regions 2018-2023
CHAPTER 3 NORTH AMERICA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole North America Market Status by Types
3.1.1 Consumption Volume of Obesity Treatment in North America by Types
3.1.2 Revenue of Obesity Treatment in North America by Types
3.2 North America Market Status by Types in Major Countries
3.2.1 Market Status by Types in United States
3.2.2 Market Status by Types in Canada
3.2.3 Market Status by Types in Mexico
3.3 Market Forecast of Obesity Treatment in North America by Types
CHAPTER 4 NORTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Obesity Treatment in North America by Downstream Industry
4.2 Demand Volume of Obesity Treatment by Downstream Industry in Major Countries
4.2.1 Demand Volume of Obesity Treatment by Downstream Industry in United States
4.2.2 Demand Volume of Obesity Treatment by Downstream Industry in Canada
4.2.3 Demand Volume of Obesity Treatment by Downstream Industry in Mexico
4.3 Market Forecast of Obesity Treatment in North America by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF OBESITY TREATMENT
5.1 North America Economy Situation and Trend Overview
5.2 Obesity Treatment Downstream Industry Situation and Trend Overview
CHAPTER 6 OBESITY TREATMENT MARKET COMPETITION STATUS BY MAJOR PLAYERS IN NORTH AMERICA
6.1 Sales Volume of Obesity Treatment in North America by Major Players
6.2 Revenue of Obesity Treatment in North America by Major Players
6.3 Basic Information of Obesity Treatment by Major Players
6.3.1 Headquarters Location and Established Time of Obesity Treatment Major Players
6.3.2 Employees and Revenue Level of Obesity Treatment Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 OBESITY TREATMENT MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 NutriSystem, Inc. (U.S.)
7.1.1 Company profile
7.1.2 Representative Obesity Treatment Product
7.1.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of NutriSystem, Inc. (U.S.)
7.2 Kellogg Company (U.S.)
7.2.1 Company profile
7.2.2 Representative Obesity Treatment Product
7.2.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Kellogg Company (U.S.)
7.3 Ethicon, Inc. (U.S.)
7.3.1 Company profile
7.3.2 Representative Obesity Treatment Product
7.3.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Ethicon, Inc. (U.S.)
7.4 Medtronic (U.S.)
7.4.1 Company profile
7.4.2 Representative Obesity Treatment Product
7.4.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Medtronic (U.S.)
7.5 F. Hoffmann-La Roche (Switzerland)
7.5.1 Company profile
7.5.2 Representative Obesity Treatment Product
7.5.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche (Switzerland)
7.6 Atkins Nutritionals, Inc. (U.S.)
7.6.1 Company profile
7.6.2 Representative Obesity Treatment Product
7.6.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Atkins Nutritionals, Inc. (U.S.)
7.7 Herbalife Ltd. (U.S.)
7.7.1 Company profile
7.7.2 Representative Obesity Treatment Product
7.7.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Herbalife Ltd. (U.S.)
7.8 Covidien plc (U.S.)
7.8.1 Company profile
7.8.2 Representative Obesity Treatment Product
7.8.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Covidien plc (U.S.)
7.9 Apollo Endosurgery (U.S.)
7.9.1 Company profile
7.9.2 Representative Obesity Treatment Product
7.9.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Apollo Endosurgery (U.S.)
7.10 Amer Sports (Finland)
7.10.1 Company profile
7.10.2 Representative Obesity Treatment Product
7.10.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Amer Sports (Finland)
7.11 Johnson Health Technology, Ltd. (Taiwan)
7.11.1 Company profile
7.11.2 Representative Obesity Treatment Product
7.11.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Johnson Health Technology, Ltd. (Taiwan)
7.12 Cybex International (U.S.)
7.12.1 Company profile
7.12.2 Representative Obesity Treatment Product
7.12.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Cybex International (U.S.)
7.13 USGI Medical (U.S.)
7.13.1 Company profile
7.13.2 Representative Obesity Treatment Product
7.13.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of USGI Medical (U.S.)
7.14 Olympus Corporation (Japan)
7.14.1 Company profile
7.14.2 Representative Obesity Treatment Product
7.14.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Olympus Corporation (Japan)
7.15 Brunswick Corporation (U.S.)
7.15.1 Company profile
7.15.2 Representative Obesity Treatment Product
7.15.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Brunswick Corporation (U.S.)
7.16 Technogym SpA (Italy)
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF OBESITY TREATMENT
8.1 Industry Chain of Obesity Treatment
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF OBESITY TREATMENT
9.1 Cost Structure Analysis of Obesity Treatment
9.2 Raw Materials Cost Analysis of Obesity Treatment
9.3 Labor Cost Analysis of Obesity Treatment
9.4 Manufacturing Expenses Analysis of Obesity Treatment
CHAPTER 10 MARKETING STATUS ANALYSIS OF OBESITY TREATMENT
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Obesity Treatment in This Report
1.2 Commercial Types of Obesity Treatment
1.2.1 Surgical & Implant Devices
1.2.2 Medication Therapy
1.2.3 Dietary
1.2.4 Other
1.3 Downstream Application of Obesity Treatment
1.3.1 Children
1.3.2 Adults
1.4 Development History of Obesity Treatment
1.5 Market Status and Trend of Obesity Treatment 2013-2023
1.5.1 North America Obesity Treatment Market Status and Trend 2013-2023
1.5.2 Regional Obesity Treatment Market Status and Trend 2013-2023
CHAPTER 2 NORTH AMERICA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Obesity Treatment in North America 2013-2017
2.2 Consumption Market of Obesity Treatment in North America by Regions
2.2.1 Consumption Volume of Obesity Treatment in North America by Regions
2.2.2 Revenue of Obesity Treatment in North America by Regions
2.3 Market Analysis of Obesity Treatment in North America by Regions
2.3.1 Market Analysis of Obesity Treatment in United States 2013-2017
2.3.2 Market Analysis of Obesity Treatment in Canada 2013-2017
2.3.3 Market Analysis of Obesity Treatment in Mexico 2013-2017
2.4 Market Development Forecast of Obesity Treatment in North America 2018-2023
2.4.1 Market Development Forecast of Obesity Treatment in North America 2018-2023
2.4.2 Market Development Forecast of Obesity Treatment by Regions 2018-2023
CHAPTER 3 NORTH AMERICA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole North America Market Status by Types
3.1.1 Consumption Volume of Obesity Treatment in North America by Types
3.1.2 Revenue of Obesity Treatment in North America by Types
3.2 North America Market Status by Types in Major Countries
3.2.1 Market Status by Types in United States
3.2.2 Market Status by Types in Canada
3.2.3 Market Status by Types in Mexico
3.3 Market Forecast of Obesity Treatment in North America by Types
CHAPTER 4 NORTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Obesity Treatment in North America by Downstream Industry
4.2 Demand Volume of Obesity Treatment by Downstream Industry in Major Countries
4.2.1 Demand Volume of Obesity Treatment by Downstream Industry in United States
4.2.2 Demand Volume of Obesity Treatment by Downstream Industry in Canada
4.2.3 Demand Volume of Obesity Treatment by Downstream Industry in Mexico
4.3 Market Forecast of Obesity Treatment in North America by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF OBESITY TREATMENT
5.1 North America Economy Situation and Trend Overview
5.2 Obesity Treatment Downstream Industry Situation and Trend Overview
CHAPTER 6 OBESITY TREATMENT MARKET COMPETITION STATUS BY MAJOR PLAYERS IN NORTH AMERICA
6.1 Sales Volume of Obesity Treatment in North America by Major Players
6.2 Revenue of Obesity Treatment in North America by Major Players
6.3 Basic Information of Obesity Treatment by Major Players
6.3.1 Headquarters Location and Established Time of Obesity Treatment Major Players
6.3.2 Employees and Revenue Level of Obesity Treatment Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 OBESITY TREATMENT MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 NutriSystem, Inc. (U.S.)
7.1.1 Company profile
7.1.2 Representative Obesity Treatment Product
7.1.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of NutriSystem, Inc. (U.S.)
7.2 Kellogg Company (U.S.)
7.2.1 Company profile
7.2.2 Representative Obesity Treatment Product
7.2.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Kellogg Company (U.S.)
7.3 Ethicon, Inc. (U.S.)
7.3.1 Company profile
7.3.2 Representative Obesity Treatment Product
7.3.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Ethicon, Inc. (U.S.)
7.4 Medtronic (U.S.)
7.4.1 Company profile
7.4.2 Representative Obesity Treatment Product
7.4.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Medtronic (U.S.)
7.5 F. Hoffmann-La Roche (Switzerland)
7.5.1 Company profile
7.5.2 Representative Obesity Treatment Product
7.5.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche (Switzerland)
7.6 Atkins Nutritionals, Inc. (U.S.)
7.6.1 Company profile
7.6.2 Representative Obesity Treatment Product
7.6.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Atkins Nutritionals, Inc. (U.S.)
7.7 Herbalife Ltd. (U.S.)
7.7.1 Company profile
7.7.2 Representative Obesity Treatment Product
7.7.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Herbalife Ltd. (U.S.)
7.8 Covidien plc (U.S.)
7.8.1 Company profile
7.8.2 Representative Obesity Treatment Product
7.8.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Covidien plc (U.S.)
7.9 Apollo Endosurgery (U.S.)
7.9.1 Company profile
7.9.2 Representative Obesity Treatment Product
7.9.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Apollo Endosurgery (U.S.)
7.10 Amer Sports (Finland)
7.10.1 Company profile
7.10.2 Representative Obesity Treatment Product
7.10.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Amer Sports (Finland)
7.11 Johnson Health Technology, Ltd. (Taiwan)
7.11.1 Company profile
7.11.2 Representative Obesity Treatment Product
7.11.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Johnson Health Technology, Ltd. (Taiwan)
7.12 Cybex International (U.S.)
7.12.1 Company profile
7.12.2 Representative Obesity Treatment Product
7.12.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Cybex International (U.S.)
7.13 USGI Medical (U.S.)
7.13.1 Company profile
7.13.2 Representative Obesity Treatment Product
7.13.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of USGI Medical (U.S.)
7.14 Olympus Corporation (Japan)
7.14.1 Company profile
7.14.2 Representative Obesity Treatment Product
7.14.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Olympus Corporation (Japan)
7.15 Brunswick Corporation (U.S.)
7.15.1 Company profile
7.15.2 Representative Obesity Treatment Product
7.15.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Brunswick Corporation (U.S.)
7.16 Technogym SpA (Italy)
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF OBESITY TREATMENT
8.1 Industry Chain of Obesity Treatment
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF OBESITY TREATMENT
9.1 Cost Structure Analysis of Obesity Treatment
9.2 Raw Materials Cost Analysis of Obesity Treatment
9.3 Labor Cost Analysis of Obesity Treatment
9.4 Manufacturing Expenses Analysis of Obesity Treatment
CHAPTER 10 MARKETING STATUS ANALYSIS OF OBESITY TREATMENT
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
